ESTIMATED
05/09/2024
05/09/2024
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.43 | -$0.43 | -$0.43 |
Q2 2024 | 1 | -$0.55 | -$0.55 | -$0.55 |
Q3 2024 | 0 | -$0.57 | -$0.57 | -$0.57 |
Q4 2024 | 0 | -$0.60 | -$0.60 | -$0.60 |
Lantern Pharma Inc. last posted its earnings results on Thursday, May 9th, 2024. The company reported $-0.51 earnings per share for the quarter, missing analysts' consensus estimates of $-0.43 by $0.08. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Lantern Pharma Inc. has generated $-1 earnings per share over the last year ($-1.47 diluted earnings per share) and currently has a price-to-earnings ratio of -2.68. Lantern Pharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/09/2024 | Q1 2024 | -$0.43 | -$0.51 | -0.08 | $0 | $0 | 03/18/2024 | Q4 2023 | -$0.40 | -$0.39 | 0.01 | $0 | $261,052 | 11/08/2023 | Q3 2023 | -$0.46 | -$0.29 | 0.17 | $0 | 08/09/2023 | Q2 2023 | -$0.40 | -$0.44 | -0.04 | $0 | 05/09/2023 | Q1 2023 | -$0.48 | -$0.32 | 0.16 | $0 | 03/20/2023 | Q4 2022 | -$0.49 | -$0.27 | 0.22 | $0 | 11/07/2022 | Q3 2022 | -$0.54 | -$0.22 | 0.32 | $0 | 08/08/2022 | Q2 2022 | -$0.52 | -$0.42 | 0.1 | $0 | 05/03/2022 | Q1 2022 | -$0.29 | -$0.38 | -0.09 | $0 | 03/10/2022 | Q4 2021 | -$0.40 | -$0.32 | 0.08 | $0 | 11/01/2021 | Q3 2021 | -$0.27 | -$0.36 | -0.09 | $0 | 07/29/2021 | Q2 2021 | -$0.26 | -$0.21 | 0.05 | $0 | 05/03/2021 | Q1 2021 | -$0.26 | -$0.24 | 0.02 | $0 | 03/10/2021 | Q4 2020 | -$0.47 | -$0.47 | 0 | $0 | 10/29/2020 | Q3 2020 | -$0.33 | -$0.27 | 0.06 | $0 | 07/30/2020 | Q2 2020 | -$0.37 | -$0.31 | 0.06 | $0 | 03/30/2020 | Q1 2020 | -$0.08 | $0 | 12/30/2019 | Q4 2019 | -$0.11 | $0 | 09/29/2019 | Q3 2019 | -$0.11 | $0 | 06/29/2019 | Q2 2019 | -$0.10 | $0 |
---|
A. Lantern Pharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates.
A. The conference call for Lantern Pharma Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Lantern Pharma Inc.'s latest earnings report can be read online.
A. Lantern Pharma Inc. (NASDAQ:LTRN) has a recorded net income of $0. Lantern Pharma Inc. has generated $-1.47 earnings per share over the last four quarters.
A. Lantern Pharma Inc. (NASDAQ:LTRN) has a price-to-earnings ratio of -2.68 and price/earnings-to-growth ratio is 0.21.